欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > CytoskeletalSignaling > Lifitegrast

浏览历史

S81722

Lifitegrast

源叶(MedMol) 99%
  • 英文名:
  • Lifitegrast
  • 别名:
  • (S)-2-[2-(苯并呋喃-6-羰基)-5,7-二氯-1,2,3,4-四氢异喹啉-6-甲酰胺基]-3-(3-甲磺酰基苯基)丙酸;SAR1118; Lifitegrast(SAR 1118); Lifitegrast;
  • CAS号:
  • 1025967-78-5
  • 分子式:
  • C29H24Cl2N2O7S
  • 分子量:
  • 615.4811
  • 核磁/质谱:
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S81722-1mg 99% ¥190.40元 3 - - - EA 加入购物车
源叶(MedMol) S81722-2mg 99% ¥340.00元 3 - - - EA 加入购物车
源叶(MedMol) S81722-5mg 99% ¥537.20元 4 - - - EA 加入购物车
源叶(MedMol) S81722-10mg 99% ¥918.00元 >10 - - - EA 加入购物车
源叶(MedMol) S81722-25mg 99% ¥1428.00元 5 - - - EA 加入购物车
源叶(MedMol) S81722-50mg 99% ¥2176.00元 5 - - - EA 加入购物车
源叶(MedMol) S81722-100mg 99% ¥3264.00元 5 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献(1篇)

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: Lifitegrast (SAR 1118) is a potent integrin antagonist. Lifitegrast blocks the binding of intercellular adhesion molecule 1 (ICAM-1) to lymphocyte function-associated antigen 1 (LFA-1), interrupting the T cell-mediated inflammatory cycle. Lifitegrast inhibits Jurkat T cell attachment to ICAM-1 with an IC50 of 2.98 nM. Lifitegrast can be used for researching dry eye disease
  • 靶点: αLβ2;Integrin
  • 体外研究:
    Lifitegrast (SAR 1118) inhibits T cell-mediated inflammation by blocking the binding of two important cell surface proteins (lymphocyte function-associated antigen 1 and intercellular adhesion molecule 1), thus lessening overall inflammatory responses. Lifitegrast strongly inhibits Jurkat T cell attachment to ICAM-1 with an IC50 of 2.98 nM
  • 体内研究:
    Lifitegrast (SAR 1118), has potent anti-inflammatory activity on corneal inflammation induced by antibiotic-killed P. aeruginosa and S. aureus in the presence of a silicone hydrogel lens with the optimal application being a 1% solution applied either 2 or 3 times prior. Lifitegrast (SAR 1118) ophthalmic drops administered thrice daily deliver therapeutic levels of Lifitegrast (SAR 1118) in the retina and can alleviate the retinal complications associated with diabetes
  • 参考文献:
    1. Perez VL, et al. Lifitegrast, a Novel Integrin Antagonist for Treatment of Dry Eye Disease. Ocul Surf. 2016 Apr;14(2):207-15. 2. Sun Y, et al. Corneal inflammation is inhibited by the LFA-1 antagonist, lifitegrast (SAR 1118). J Ocul Pharmacol Ther. 2013 May;29(4):395-402. 3. Rao VR, et al. Delivery of SAR 1118 to the retina via ophthalmic drops and its effectiveness in a rat streptozotocin(STZ) model of diabetic retinopathy (DR). Invest Ophthalmol Vis Sci. 2010 Oct;51(10):5198-204.
  • 溶解性: soluble  in  DMSO
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 1.625 ml 8.124 ml 16.247 ml
    5 mM 0.325 ml 1.625 ml 3.249 ml
    10 mM 0.162 ml 0.812 ml 1.625 ml
    50 mM 0.032 ml 0.162 ml 0.325 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。